Rockwell Medical Inc
NASDAQ:RMTI
Intrinsic Value
Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. [ Read More ]
The intrinsic value of one RMTI stock under the Base Case scenario is 1.78 USD. Compared to the current market price of 1.49 USD, Rockwell Medical Inc is Undervalued by 16%.
Valuation Backtest
Rockwell Medical Inc
Run backtest to discover the historical profit from buying and selling RMTI stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Rockwell Medical Inc
Current Assets | 28.2m |
Cash & Short-Term Investments | 11.7m |
Receivables | 9.4m |
Other Current Assets | 7.1m |
Non-Current Assets | 24.4m |
PP&E | 11.9m |
Intangibles | 11.8m |
Other Non-Current Assets | 705k |
Current Liabilities | 21.4m |
Accounts Payable | 3.9m |
Accrued Liabilities | 8.2m |
Short-Term Debt | 488k |
Other Current Liabilities | 8.8m |
Non-Current Liabilities | 9.7m |
Long-Term Debt | 5m |
Other Non-Current Liabilities | 4.7m |
Earnings Waterfall
Rockwell Medical Inc
Revenue
|
80.8m
USD
|
Cost of Revenue
|
-72.7m
USD
|
Gross Profit
|
8.2m
USD
|
Operating Expenses
|
-16.3m
USD
|
Operating Income
|
-8.1m
USD
|
Other Expenses
|
-1.2m
USD
|
Net Income
|
-9.3m
USD
|
Free Cash Flow Analysis
Rockwell Medical Inc
RMTI Profitability Score
Profitability Due Diligence
Rockwell Medical Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
Score
Rockwell Medical Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
RMTI Solvency Score
Solvency Due Diligence
Rockwell Medical Inc's solvency score is 39/100. The higher the solvency score, the more solvent the company is.
Score
Rockwell Medical Inc's solvency score is 39/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
RMTI Price Targets Summary
Rockwell Medical Inc
According to Wall Street analysts, the average 1-year price target for RMTI is 7.14 USD with a low forecast of 5.05 USD and a high forecast of 9.45 USD.
Ownership
RMTI Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
RMTI Price
Rockwell Medical Inc
Average Annual Return | -60.37% |
Standard Deviation of Annual Returns | 12.91% |
Max Drawdown | -99% |
Market Capitalization | 42.4m USD |
Shares Outstanding | 29 334 600 |
Percentage of Shares Shorted | 2.31% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. The company is headquartered in Wixom, Michigan and currently employs 300 full-time employees. The firm is developing and commercializing its technology platform, Ferric Pyrophosphate Citrate (FPC) for the transformative treatments for iron deficiency in multiple disease states. The company is also a supplier of hemodialysis concentrate products to kidney dialysis clinics. The firm has developed therapies namely Triferic and Triferic AVNU from its FPC platform. The Company’s products from its FPC platform, Triferic (dialysate) and Triferic AVNU intravenous (IV), is a therapy indicated to replace iron and maintain hemoglobin in adult hemodialysis patients. Its Triferic AVNU, is an IV formulation of Triferic, for use by hemodialysis patients. its dialysis concentrates products include CitraPure Citric Acid Concentrate, Dri-Sate Dry Acid Concentrate, RenalPure Liquid Acid Concentrate, Dry Acid Concentrate Mixer, RenalPure and SteriLyte Bicarbonate Concentrate and Ancillary products.
Contact
IPO
Employees
Officers
The intrinsic value of one RMTI stock under the Base Case scenario is 1.78 USD.
Compared to the current market price of 1.49 USD, Rockwell Medical Inc is Undervalued by 16%.